Aniket A Kawatkar1, Adam L Sharp1, Aileen S Baecker1, Shaw Natsui2, Rita F Redberg3,4, Ming-Sum Lee5, Maros Ferencik6, Yi-Lin Wu1, Ernest Shen1, Chengyi Zheng1, Visanee V Musigdilok1, Michael K Gould1, Steve Goodacre7, Praveen Thokala7, Benjamin C Sun8. 1. Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena. 2. National Clinician Scholars Program, Department of Emergency Medicine, University of California, Los Angeles. 3. Division of Cardiology, Department of Medicine, School of Medicine, University of California, San Francisco. 4. Editor, JAMA Internal Medicine. 5. Division of Cardiology, Los Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles. 6. Knight Cardiovascular Institute, Oregon Health and Science University, Portland. 7. School of Health and Related Research, The University of Sheffield, Sheffield, United Kingdom. 8. Leonard Davis Institute of Health Economics, Department of Emergency Medicine, University of Pennsylvania, Philadelphia.
Abstract
Importance: Professional guidelines recommend noninvasive cardiac testing (NIT) within 72 hours of an emergency department (ED) evaluation for suspected acute coronary syndrome. However, there is inexact evidence that this strategy reduces the risk of future death or acute myocardial infarction (MI). Objective: To evaluate the effectiveness of early NIT in reducing the risk of death or acute MI within 30 days. Design, Setting, and Participants: This retrospective, multicenter cohort study within the Kaiser Permanente Southern California integrated health care delivery system compared the effectiveness of early noninvasive cardiac testing vs no testing in patients with chest pain and in whom acute MI was ruled out who presented to an ED from January 2015 to December 2017. Patients were followed up for up to 30 days after emergency department discharge. Exposures: Noninvasive cardiac testing performed within 3 days of an ED evaluation for suspected acute coronary syndrome. Main Outcomes and Measures: The primary outcome was composite risk of death or acute MI, within 30 days of an ED discharge. Results: A total of 79 040 patients were evaluated in this study, of whom 57.7% were female. The mean (SD) age of the cohort was 57 (16) years, and 16 164 patients (21%) had completed early NIT. The absolute risk of death or MI within 30 days was low (<1%). Early NIT had the minor benefit of reducing the absolute composite risk of death or MI (0.4% [95% CI, -0.6% to -0.3%]), and, separately, of death (0.2% [95% CI, -0.2% to -0.1%]), MI (-0.3% [95% CI, -0.5% to -0.1%]), and major adverse cardiac event (-0.5% [95% CI, -0.7% to -0.3%]). The number needed to treat was 250 to avoid 1 death or MI, 500 to avoid 1 death, 333 to avoid 1 MI, and 200 to avoid 1 major adverse cardiovascular event within 30 days. Subgroup analysis revealed a number needed to treat of 14 to avoid 1 death or MI in the subset of patients with elevated troponin. Conclusions and Relevance: Early NIT was associated with a small decrease in the risk of death or MI in patients admitted to the ED with suspected acute coronary syndrome, but this clinical strategy may not be optimal for most patients given the large number needed to treat.
Importance: Professional guidelines recommend noninvasive cardiac testing (NIT) within 72 hours of an emergency department (ED) evaluation for suspected acute coronary syndrome. However, there is inexact evidence that this strategy reduces the risk of future death or acute myocardial infarction (MI). Objective: To evaluate the effectiveness of early NIT in reducing the risk of death or acute MI within 30 days. Design, Setting, and Participants: This retrospective, multicenter cohort study within the Kaiser Permanente Southern California integrated health care delivery system compared the effectiveness of early noninvasive cardiac testing vs no testing in patients with chest pain and in whom acute MI was ruled out who presented to an ED from January 2015 to December 2017. Patients were followed up for up to 30 days after emergency department discharge. Exposures: Noninvasive cardiac testing performed within 3 days of an ED evaluation for suspected acute coronary syndrome. Main Outcomes and Measures: The primary outcome was composite risk of death or acute MI, within 30 days of an ED discharge. Results: A total of 79 040 patients were evaluated in this study, of whom 57.7% were female. The mean (SD) age of the cohort was 57 (16) years, and 16 164 patients (21%) had completed early NIT. The absolute risk of death or MI within 30 days was low (<1%). Early NIT had the minor benefit of reducing the absolute composite risk of death or MI (0.4% [95% CI, -0.6% to -0.3%]), and, separately, of death (0.2% [95% CI, -0.2% to -0.1%]), MI (-0.3% [95% CI, -0.5% to -0.1%]), and major adverse cardiac event (-0.5% [95% CI, -0.7% to -0.3%]). The number needed to treat was 250 to avoid 1 death or MI, 500 to avoid 1 death, 333 to avoid 1 MI, and 200 to avoid 1 major adverse cardiovascular event within 30 days. Subgroup analysis revealed a number needed to treat of 14 to avoid 1 death or MI in the subset of patients with elevated troponin. Conclusions and Relevance: Early NIT was associated with a small decrease in the risk of death or MI in patients admitted to the ED with suspected acute coronary syndrome, but this clinical strategy may not be optimal for most patients given the large number needed to treat.
Authors: Adam L Sharp; Aniket A Kawatkar; Aileen S Baecker; Rita F Redberg; Ming-Sum Lee; Maros Ferencik; Yi-Lin Wu; Ernest Shen; Chengyi Zheng; Stacy Park; Steve Goodacre; Praveen Thokala; Benjamin C Sun Journal: J Gen Intern Med Date: 2021-05-14 Impact factor: 5.128
Authors: Sefer Elezkurtaj; Selina Greuel; Jana Ihlow; Edward Georg Michaelis; Philip Bischoff; Catarina Alisa Kunze; Bruno Valentin Sinn; Manuela Gerhold; Kathrin Hauptmann; Barbara Ingold-Heppner; Florian Miller; Hermann Herbst; Victor Max Corman; Hubert Martin; Helena Radbruch; Frank L Heppner; David Horst Journal: Sci Rep Date: 2021-02-19 Impact factor: 4.379
Authors: Dustin G Mark; Jie Huang; Dustin W Ballard; Mamata V Kene; Dana R Sax; Uli K Chettipally; James S Lin; Sean C Bouvet; Dale M Cotton; Megan L Anderson; Ian D McLachlan; Laura E Simon; Judy Shan; Adina S Rauchwerger; David R Vinson; Mary E Reed Journal: J Am Heart Assoc Date: 2021-11-06 Impact factor: 5.501
Authors: Lei Liu; Qiu Xi Zeng; Hang Qu; Jun Jian Li; Yan Wei Yang; Yan Wen Gong; Zhong Zhi He; Yi He Zhang; Wei Zhang; Bin Liu; Li Chun Che Journal: Clin Exp Med Date: 2021-10-22 Impact factor: 5.057
Authors: Christoph Spinner; Jörg Janne Vehreschild; Carolin E M Jakob; Stefan Borgmann; Fazilet Duygu; Uta Behrends; Martin Hower; Uta Merle; Anette Friedrichs; Lukas Tometten; Frank Hanses; Norma Jung; Siegbert Rieg; Kai Wille; Beate Grüner; Hartwig Klinker; Nicole Gersbacher-Runge; Kerstin Hellwig; Lukas Eberwein; Sebastian Dolff; Dominic Rauschning; Michael von Bergwelt-Baildon; Julia Lanznaster; Richard Strauß; Janina Trauth; Katja de With; Maria Ruethrich; Catherina Lueck; Jacob Nattermann; Lene Tscharntke; Lisa Pilgram; Sandra Fuhrmann; Annika Classen; Melanie Stecher; Maximilian Schons Journal: Infection Date: 2020-10-01 Impact factor: 7.455